(1) Whether any applications were received for the registration of medicines and amendments to dossiers (a) in (i) 2005, (ii) 2006, (iii) 2007 and (iv) 2008 and (b) during the period 1 January 2009 up to the latest specified date for which information is available; if so, (i) how many in each case, (ii) on which date was each application submitted, (iii) what conditions/illnesses was each application for, (iv) what are the names of the medicines in each application and (v) which applications (aa) have been registered and (bb) have not been registered; (2) (a) how many additional clinical evaluators have been appointed in the past two financial years, (b) on what date was each evaluator appointed and (c) how many applications have they completed since their appointment; Friday, 14 August 2009 223 INTERNAL QUESTION PAPER: NATIONAL ASSEMBLY NO 9 - 2009 (3) whether, with regard to the current backlog, there are any steps to allow for the registration of medicines that have been approved by certain acceptable countries, similar to that of Singapore; if not, (a) why not and (b) by what date will the backlog be addressed; if so, (i) when will this come into effect and (ii) which countries are acceptable?